As of 2015, new advances in treating heart disease include a new medication for treating heart failure and a class of drugs to control cholesterol levels, says Everyday Health. Additionally, the Food and Drug Administration recently approved transcatheter aortic valve replacement, a less invasive surgery procedure for heart valve disease.
LCZ696 is the promising new heart failure drug that can reduce deaths and hospitalizations for heart disease sufferers, according to Everyday Health. LCZ696 has the potential to reduce the appreciable burden repeat hospitalization places on health care organizations. PSCK9 inhibitors are new medicines that can reduce cholesterol levels without creating serious adverse effects in heart disease patients.